Analysen von Keyur Parekh
| 11.09.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.09.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 06.09.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 30.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 17.08.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 10.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 08.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 08.08.17 | GSK buy | Goldman Sachs Group Inc. | |
| 08.08.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 07.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 04.08.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 02.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 28.07.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 27.07.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 26.07.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 24.07.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 24.07.17 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 20.07.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.07.17 | GSK buy | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.07.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.06.17 | Bayer buy | Goldman Sachs Group Inc. | |
| 27.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 23.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 14.06.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.06.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.05.17 | GSK buy | Goldman Sachs Group Inc. | |
| 30.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.05.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.05.17 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 19.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.05.17 | Merck Neutral | Goldman Sachs Group Inc. | |
| 17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.05.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.05.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |